National genomic profiling of <i>Plasmodium falciparum</i> antimalarial resistance in Zambian children participating in the 2018 Malaria Indicator Survey
Abebe A. Fola(John Brown University), Giovanna Carpi(Yale University), Brenda Mambwe(Ministry of Health), Rachael Kasaro(Ministry of Health), Busiku Hamainza(Ministry of Health), John Miller, Ilinca I. Ciubotariu(Purdue University West Lafayette), Conceptor Mulube(Ministry of Health), William J. Moss(Johns Hopkins University), Mulenga Mwenda(United Arab Emirates University), Daniel J. Bridges(Ministry of Health), Jack Dorman(Johns Hopkins University), Moonga Hawela(Ministry of Health), Jeffrey A. Bailey(John Brown University)
Cited by 2
Related Papers
Deployment of convalescent plasma for the prevention and treatment of COVID-19
|Journal of Clinical Investigation|2020|863
A Worldwide Map of<i>Plasmodium falciparum</i>K13-Propeller Polymorphisms
|New England Journal of Medicine|2016|574
Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia
|Nature Microbiology|2023|190
Drug-Resistance and Population Structure of Plasmodium falciparum Across the Democratic Republic of Congo Using High-Throughput Molecular Inversion Probes
|The Journal of Infectious Diseases|2018|147
Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance
|The Lancet Infectious Diseases|2024|99